Six-fold difference in the stomach cancer mortality rate between northern and southern Iran

Archives of Iranian Medicine

Volumn 15, Issue 12, 2012, Pages 741-746

  Zendehdel, Kazem ^a   Marzban, Maryam ^b,c   Nahvijou, Azin ^a   Jafari, Nahid ^d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

Author keywords

Cancer; Epidemiology; Iran; Mortality; Stomach

Indexed keywords

ARTICLE; CANCER MORTALITY; ENVIRONMENTAL FACTOR; GEOGRAPHIC DISTRIBUTION; HELICOBACTER INFECTION; HUMAN; IRAN; PREVALENCE; RURAL POPULATION; SEX RATIO; STANDARDIZED MORTALITY RATIO; STOMACH CANCER; URBAN POPULATION;

FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IRAN; MALE; PREVALENCE; RISK FACTORS; SMOKING; STOMACH NEOPLASMS;

EID: 84871256876     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Ferlay J, Shin H, Bray F, Forman D, Mathers C. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide. Lyon, France: International Agency for Research on Cancer; 2010.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55: 74-108.
3. Fock KM, Talley N, Moayyedi P, Hunt R Azuma T, Sugano K, et al. Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol. 2008; 23: 351-365.
4. Sadjadi A, Nouraie M, Mohagheghi MA, Mousavi-Jarrahi A, Malekezadeh R Parkin DM. Cancer occurrence in Iran in 2002, an international perspective. AsianPac J CancerPrev. 2005; 6: 359-363.
5. Mohagheghi MA, Mosavi-Jarrahi A, Malekzadeh R, Parkin M. Cancer incidence in Tehran metropolis: the first report from the Tehran Population-based Cancer Registry, 1998-2001. Arch Iran Med. 2009; 12: 15-23.
6. Babaei M, Mousavi S, Malek M, Tosi G, Masoumeh Z, Danaei N, et al. Cancer occurrence in Semnan Province, Iran: results of a population-based cancer registry. Asian Pac J Cancer Prev. 2005; 6: 159-164.
7. Sadjadi A, Malekzadeh R Derakhshan MH, Sepehr A, Nouraie M, Sotoudeh M, et al. Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran. Int J Cancer. 2003; 107: 113-118.
8. Sadjadi A, Zahedi M, Darvish Moghadam S, Nouraie M, Alimohammadian M, Ghrbani A, et al. The first population-based cancer survey in Kerman Province of Iran. Iranian J Pub Health. 2007; 36: 26-34.
9. Akbari M, Zolfeghari H. A geopolitical analysis of ethnicity in Iran, with an emphesis and opportunities. Geopoilitics Quarterly. 2009; 5: 45-69.
10. Malekzadeh R, Sotoudeh M, Derakhshan MH, Mikaeli J, Yazdanbod A, Merat S, et al. Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the northwest of Iran. J Clin Pathol. 2004; 57: 37-42.
11. Zendehdel K, Sedighi Z, Hassanloo J, Nahvijou A. Improving quality of cancer registration in Iran. Part 1: evaluation and comparison of cancer registration results in the country. Hakim Res J. 2010; 12: 42-49.
12. Naghavi, Jafari N. Pattern ofMortality in 29Provinces ofIslamic Republic of Iran Year for Year 2005 [in Persian]. Tehran: Iranina Ministry of Medical Education; 2008.
13. Jensen O, Parkin DM, Maclenan R, Muir CS, Skeet RG. Cancer Registration: Principles and Methods. Lyon: IARC press; 1991.
14. Metanat M, Sharifi-Mood B, Izadi S. Prevalence of Helicobacter Pylori infection in healthcare workers. Turk J Med Sci. 2010; 40: 965-969.
15. Zahedi M, Darvishmoghadam S, Atapoor M,. Prevalence ofH. Pylori infection among patients and general population referering to the health care centers of Kerman City in 2000. J Kerman Univ Med Sci. 2002; 9: 140-145.
16. Jarfarzadeh A, Sajadi M, Rashidinejad H. Prevelance of IgA Anti-H. pylori antbody among blood donors in Rafsanjan City, Iran. Tabib-e-Shragh. 2006; 8: 101-109.
17. Parkin D, Chen V, Frelay J, Storm H. Comparability and Quality Control in Cancer Registration. Lyon: International Agency for Research on Cancer; 1994.
18. Babaei M, Jaafarzadeh H, Sadjadi AR, Samadi F, Yazdanbod A, Fallah M, et al. Cancer incidence and mortality in Ardabil: report of an ongoing populationbased cancer registry in Iran, 2004-2006. Iranian JPublHealth. 2009; 38: 35-45.
19. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut. 2001; 49: 347-353.
20. Persson C, Jia Y, Pettersson H, Dillner J, Nyren O, Ye W. H. pylori seropositivity before age 40 and subsequent risk of stomach cancer: a glimpse of the true relationship? PLoS One. 2011; 6: e17404.
21. Lin Y, Ueda J, Kikuchi S, Totsuka Y, Wei WQ, Qiao YL, et al. Comparative epidemiology of gastric cancer between Japan and China. WorldJ Gastroenterol. 2011; 17: 4421-4428.
22. Nyren O, Adami HO. Stomach cancer. In: Adami HO, Hunter D, Trichopoulos D, eds. Textbook of Cancer Epidemiology. New York: Oxford University Press; 2008.
23. Tredaniel J, Boffetta P, Buiatti E, Saracci R Hirsch A. Tobacco smoking and gastric cancer: review and meta-analysis. Int J Cancer. 1997; 72: 565-573.
24. Malekzadeh R Derakhshan MH, Malekzadeh Z. Gastric cancer in Iran: epidemiology and risk factors. Arch Iran Med. 2009; 12: 576-583.
25. Shekholeslami H, Ghasemi-Barghi R Mousavi H. Comparison of prevelence of Helicobacter pylori Infection in Urban and Rural Area of Ghazvin. J Ghazvin Univ of Med Sci. 2004: 47-51.
26. Babamahmoodi F, Ajami A, Kalhor M, Shafeei G, Khalilian A. Seroepidemiology if H pylori infection in Sari Cirt of Iran in 2001. J Mazandaran Univ Med Sci. 2004; 43: 39-48.
27. Ghadimi R, Taheri H, Suzuki S, Kashifard M, Hosono A, Esfandiary I, et al. Host and environmental factors for gastric cancer in Babol, the Caspian Sea Coast, Iran. Eur J Cancer Prev. 2007; 16: 192-195.
28. Alizadeh A, Ansari S, Ranjbar M, Shalmani HM, Habibi I, Firouzi M, et al. Seroprevalnece of Helicobacter Pylori in Nahavand: a Population-Based Study. East Mediter Health J. 2009; 15: 129-135.